Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FTSE 100 movers: Reckitt surges on infant formula win, Schroders lifted by upgrade

(Sharecast News) - London's FTSE 100 was up 1% at 8,189.25 in afternoon trade on Friday. Reckitt Benckiser surged to the top of the index after its subsidiary Mead Johnson was cleared of liability in a US trial investigating whether it - and Abbott - hid bowel disease risks associated with premature-baby formula.

Russ Mould, investment director at AJ Bell, said: "Consumer goods firm Reckitt enjoyed a meaningful relief rally off the back of a ruling in the latest trial on disease risks associated with its baby formula.

"There has been nothing but bad news on this front for Reckitt for some time so it's not a surprise this chink of light has been seized upon by investors in a positive way. There are still plenty of outstanding cases so this issue will not go away for Reckitt overnight, but it certainly represents a crumb of comfort for long-suffering shareholders.

"An eventual resolution of this issue could be a precursor to selling the Mead Johnson business which has been nothing short of a disaster for Reckitt since it was acquired for $16.6 billion in 2017. The company is already on track to sell a portfolio of home care brands like Air Wick and Cillit Bang by the end of next year as CEO Kris Licht continues his restructure of the business."

Schroders was also in the black as BNP Paribas Exane upgraded the stock to 'outperform' from 'neutral' ahead of third-quarter results next week, as it pointed to improving momentum and an attractive valuation.

"We see these results as a potential strong positive catalyst for the stock where the company will outline positive flows in Q3 and beyond and positive fund performance momentum," it said.

"We also expect some strategic repositioning of the company which could include a cost savings program.

"Finally, we see a better outlook for Schroders' Wealth and alternative businesses as deal activity rebounds."

FTSE 100 - Risers

Reckitt Benckiser Group (RKT) 5,076.00p 8.37% Schroders (SDR) 357.40p 3.90% GSK (GSK) 1,429.00p 2.62% Beazley (BEZ) 774.00p 2.45% Intermediate Capital Group (ICG) 2,106.00p 2.13% Croda International (CRDA) 3,776.00p 1.92% Whitbread (WTB) 3,069.00p 1.86% Legal & General Group (LGEN) 221.10p 1.84% Imperial Brands (IMB) 2,379.00p 1.80% BT Group (BT.A) 140.65p 1.74%

FTSE 100 - Fallers

Smurfit Westrock (DI) (SWR) 3,917.00p -2.44% Smith (DS) (SMDS) 537.50p -1.47% Flutter Entertainment (DI) (FLTR) 18,000.00p -0.77% International Consolidated Airlines Group SA (CDI) (IAG) 209.40p -0.71% CRH (CDI) (CRH) 7,370.00p -0.32% Vistry Group (VTY) 907.00p -0.27% Prudential (PRU) 643.00p -0.25% Sainsbury (J) (SBRY) 265.60p -0.23% JD Sports Fashion (JD.) 123.75p -0.20% Entain (ENT) 744.20p -0.11%

Share this article

Related Sharecast Articles

Europe midday: Shares pare losses as investors digest China tariff move
(Sharecast News) - European stocks pared losses as investors digested China's retaliatory moves against US tariffs and the 30-day pause on levies against Canada and Mexico.
US pre-open: Futures slightly lower as tariff headlines remain in focus
(Sharecast News) - Wall Street futures were in the red ahead of the bell on Tuesday as the effects of the new White House administration's tariffs on a number of its closest trading partners continued to be seen.
Asia report: Markets bounce back from Trump tariff sell-off
(Sharecast News) - Asia-Pacific markets advanced on Tuesday as investor sentiment improved following Donald Trump's decision to pause tariffs on Mexico and Canada for a month.
London open: FTSE falls again as China retaliates against US
(Sharecast News) - London stocks were lower again in early trade on Tuesday following heavy losses a day earlier, after China announced retaliatory tariffs on a range of US imports.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.